A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US
NCT03043300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2019-01-30
Summary
This prospective, observational pilot study is designed to assess feasibility, refine the target population, and quickly test qualitative and quantitative changes in the microbiome after short-term travel to South or Southeast Asia, regions where rates of travelers' diarrhea and intestinal colonization with antimicrobial resistant bacteria are highest.
To measure the diversity change of the intestinal microbiota, participants will complete a questionnaire and provide a stool specimen at three different time points: prior to traveling, two weeks after returning from traveling, and 14 weeks after returning from traveling.
Conditions
Interventions
- OTHER
-
Screening Criteria Review
The screening criteria review is an 8 item instrument collecting information during screening about overall health, including self-reported chronic intestinal conditions, immunocompromising conditions, the use of certain medication types (immunosuppressives and antibiotics), and pregnancy status. The instrument will also collect dates of planned travel to South(east) as well as preferred dates for study visits and reminder contacts. This instrument will be administered verbally by the study team and completed no more than 4 weeks prior to travel departure from the United States.
- OTHER
-
Pre-Travel Questionnaire
The pre-travel questionnaire is a 29 item instrument collecting information about baseline characteristics, dietary habits, travel plans, and health history. This questionnaire will be administered verbally by the study team and completed 1 week prior to travel departure from the United States.
- OTHER
-
Pre-Travel Stool Specimen Collection
The pre-travel stool specimen collection will occur 1 week prior to travel departure from the United States. The processing and analyses of this stool specimen will be performed by the Centers for Disease Control and Prevention.
- OTHER
-
Short-Term Post-Travel Questionnaire
The short-term post-travel questionnaire is a 19 item instrument collecting information about dates and locations of travel, food and beverages consumed while traveling, and illnesses during or following traveling. This questionnaire will be administered verbally by the study team and completed 2 weeks after returning to the United States from travel.
- OTHER
-
Short-Term Post-Travel Stool Specimen Collection
The short-term post-travel stool specimen collection will occur 2 weeks after returning to the United States from travel. The processing and analyses of this stool specimen will be performed by the Centers for Disease Control and Prevention.
- OTHER
-
Long-Term Post-Travel Questionnaire
The long-term post-travel questionnaire is a 16 item instrument collecting information about illnesses since last study visit, dietary habits since last study visit, and any traveling since the last visit. This questionnaire will be administered verbally by the study team and completed 14 weeks after returning to the United States from travel.
- OTHER
-
Long-Term Post-Travel Stool Specimen Collection
The short-term post-travel stool specimen collection will occur 14 weeks after returning to the United States from travel. The processing and analyses of this stool specimen will be performed by the Centers for Disease Control and Prevention.
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
Emory University
lead OTHER
Principal Investigators
-
Colleen S Kraft, MD, MSc · Emory University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-11-07
- Primary Completion
- 2018-12-01
- Completion
- 2018-12-01
Countries
- United States
Study Locations
More Related Trials
-
Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
NCT03794479 ·Status: COMPLETED
-
A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program
NCT03350711 ·Status: SUSPENDED
-
Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea
NCT00098384 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch
NCT01067781 ·Status: COMPLETED ·Phase: PHASE2
-
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
NCT07261826 ·Status: RECRUITING
-
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults
NCT06839599 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years
NCT02561195 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
NCT02498301 ·Status: COMPLETED ·Phase: NA
-
Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea
NCT01070277 ·Status: UNKNOWN ·Phase: NA
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)
NCT01142089 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin
NCT00979056 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis
NCT03099408 ·Status: COMPLETED ·Phase: PHASE4
-
Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
NCT05739825 ·Status: RECRUITING
-
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
NCT05622721 ·Status: ACTIVE_NOT_RECRUITING
-
A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
NCT02117570 ·Status: COMPLETED ·Phase: PHASE2
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea
NCT02801656 ·Status: WITHDRAWN ·Phase: PHASE3
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-Drug Resistant Bacteria Carriage After Travel
NCT03477760 ·Status: COMPLETED
-
Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection
NCT03834038 ·Status: COMPLETED ·Phase: NA
-
Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization
NCT03061097 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplant for Primary CDI
NCT03795233 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan
NCT03031743 ·Status: COMPLETED